Followers | 31 |
Posts | 2649 |
Boards Moderated | 0 |
Alias Born | 10/28/2013 |
Monday, July 28, 2014 4:44:39 PM
You may recall that NW actually has to fund itself. It may have done that with warrants cashed during the many trades that went on when it got added to the Russell, but if not then this shield that has been built to keep new investors disinterested is like putting a plastic bag over NW's head.
There was a tweet yesterday about GSK making an offer. If that turns out to be true, I am going to have to wonder if GSK was behind all this. It sure as hell was not MD Anderson. They didn't call up Adam Feuerstein, it was the other way around.
Feuerstein asked Subbiah at ASCO about NW publishing data on Direct, as they said they were going to do for 6 months. According to Feuerstein, Subbiah replied that while MDA has a policy of not publishing results early, NW was free to do so.
Then two weeks later, Cramer tasked Feuerstein to poke around and get a different answer. And Feuerstein did what his boss told him and called MD Anderson, and managed to manipulate some bastard into a "rebuke". That is very different from MD Anderson going out of it's way to publicize an admonishment. They did that later only when put on the defensive.
And there is no way that LP would release data now without a clear understanding of what MDA would do in response. But if she gets data showing that there is a strong indication of a response in non-injected tumors, then that would definitely be something I would want to know about.
And big pharma would get access to that info. And it would be legal. Due to that fact, for LP to not publicize it would be questionable legally. It would put us retail investors at a tremendous disadvantage.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM